Malignant Thyroid Gland Neoplasm — Trials

Malignant Thyroid Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 176
Recruiting: 92
Ph III recruiting: 12
Growth YoY: +4.9%
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.9%
Trials / 1,000 deaths: 81.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01398085	IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients(IoN)	active not recruiting	Phase 2 / Phase 3	504	University College, LondonOTHER	1	May 7, 2026	clinicaltrials
NCT04211337	A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer(LIBRETTO-531)	active not recruiting	Phase 3	291	Loxo Oncology, Inc.INDUSTRY	20	Mar 19, 2026